Xtant Medical Launches OsteoFactor Pro A Groundbreaking Growth Factor Solution to Advance Bone Healing

Published: 30 May 2025

Author: Precedence Research

Share :

May 28, 2025

Xtant Medical Holdings, Inc., a company in spinal and orthopedic care, has now released OsteoFactor Pro, an orthobiologic product made to help bone healing and achieve better surgical results. It contains a special blend of growth factors that work together to help healing when used with any type of bone, replacing material, whether it's synthetic or from the donor.

Xtant Medical now provides every main type of orthobiologic product, which no other company in the sector offers. With the launch of OsteoFactor Pro, Orthofix wants to form part of its strategy to give surgeons reliable, top-performing biologics that assist patients during surgeries of the spine and for orthopedic treatments. Furthermore, to build its commitment to regenerative medicine, Xtant is expanding its OsteoFactor Pro's reach through its distributor partners. 

What is OsteoFactor Pro?

A ready-to-use, growth factor-rich solution that boosts bone healing by stimulating the body’s natural regeneration processes.

How It Works

Features a biphasic release—an initial high-impact dose followed by a long-lasting release of growth factors to aid healing.

Flexible Integration

Compatible with synthetic, autograft, and allograft scaffolds, giving surgeons maximum choice and flexibility in treatment strategies.

Off-the-Shelf Convenience

No special preparation or storage is required—ready to use directly in surgery.

Supports Regenerative Medicine Goals

Advances the science of biologics and aligns with future orthopedic innovation and patient recovery strategies.

Executive Statements

Sean Browne, President and CEO of Xtant Medical

“This product reflects our commitment to advancing the science of healing through biologics that offer precision, flexibility, and meaningful clinical impact.”

Mark Schallenberger, Chief Operating Officer

“With the launch of OsteoFactor Pro™, Xtant becomes the first vertically integrated company to offer solutions across all five major orthobiologic categories—this milestone reflects our long-term commitment to innovation, scalability, and meeting the full spectrum of surgeon and patient needs in regenerative medicine.”